Protalix BioTherapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 300,000 | $7.13 | $2,139,000 | 463,754 | May 2, 2012 |
| Maimon Yossi | VP, Chief Financial Officer | Option Exercise | 75,964 | $0.97 | $73,685 | 75,964 | May 2, 2012 |
| Aviezer David | President & CEO | Sale | 450,000 | $7.13 | $3,208,500 | — | May 2, 2012 |
| Almon Einat Brill | SVP, Product Development | Option Exercise | 50,000 | $2.65 | $132,500 | 166,848 | May 2, 2012 |
| Maimon Yossi | VP, Chief Financial Officer | Option Exercise | 77,769 | $0.97 | $75,436 | — | Oct 7, 2010 |
| Almon Einat Brill | VP, Product Development | Sale | 15,000 | $9.29 | $139,350 | — | Oct 4, 2010 |
| Almon Einat Brill | VP, Product Development | Option Exercise | 4,740 | $0.40 | $1,896 | — | Sep 7, 2010 |
| Maimon Yossi | VP, Chief Financial Officer | Sale | 31,500 | $8.16 | $257,040 | — | Sep 3, 2010 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 4,619 | $7.00 | $32,333 | 763,754 | Aug 5, 2010 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 52,973 | $7.00 | $370,811 | 816,781 | Jun 21, 2010 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 12,691 | $7.00 | $88,837 | 869,754 | Apr 29, 2010 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 1,309 | $7.00 | $9,163 | 882,445 | Apr 14, 2010 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 50,000 | $7.00 | $350,000 | 883,754 | Mar 24, 2010 |
| Bar-Shalev Amos | — | Purchase | 680 | $8.20 | $5,576 | 1,680 | Dec 2, 2009 |
| Hurvitz Eli | — | Sale | 1,121,967 | $10.00 | $11,219,670 | 1,764,480 | Nov 12, 2009 |
| Aviezer David | CEO and President | Tax Withholding | 3,253 | $9.13 | $29,700 | — | Oct 21, 2009 |
| Maimon Yossi | VP, Chief Financial Officer | Tax Withholding | 17,698 | $9.21 | $162,999 | — | Oct 16, 2009 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 43,120 | $9.43 | $406,622 | 1,263,754 | Oct 16, 2009 |
| Almon Einat Brill | VP, Product Development | Sale | 38,320 | $9.43 | $361,358 | — | Oct 16, 2009 |
| FROST PHILLIP MD ET AL | — | Sale | 3,200 | $7.47 | $23,904 | 7,633,007 | Sep 10, 2009 |
| FROST PHILLIP MD ET AL | — | Sale | 2,500 | $6.85 | $17,125 | 7,815,741 | Sep 3, 2009 |
| Frost Gamma Investments Trust | — | Sale | 408 | $6.02 | $2,456 | 7,863,241 | Aug 28, 2009 |
| FROST PHILLIP MD ET AL | — | Sale | 735 | $6.10 | $4,484 | 7,945,596 | Aug 26, 2009 |
| Frost Gamma Investments Trust | — | Sale | 3,116 | $6.32 | $19,693 | 7,988,048 | Aug 25, 2009 |
| Frost Gamma Investments Trust | — | Sale | 46,031 | $6.10 | $280,789 | 8,545,325 | Aug 21, 2009 |
| FROST PHILLIP MD ET AL | — | Sale | 4,551 | $6.25 | $28,444 | 8,736,099 | Aug 18, 2009 |
| Frost Gamma Investments Trust | — | Sale | 7,294 | $6.38 | $46,536 | 8,929,614 | Aug 17, 2009 |
| Frost Gamma Investments Trust | — | Sale | 3,257 | $5.95 | $19,379 | 9,155,338 | Aug 13, 2009 |
| Frost Gamma Investments Trust | — | Sale | 119 | $6.27 | $746 | 9,198,750 | Aug 12, 2009 |
| Frost Gamma Investments Trust | — | Sale | 500 | $6.16 | $3,080 | 9,413,921 | Aug 10, 2009 |
| FROST PHILLIP MD ET AL | — | Sale | 5,747 | $5.90 | $33,907 | 9,361,802 | Aug 10, 2009 |
| FROST PHILLIP MD ET AL | — | Sale | 100 | $7.00 | $700 | 9,614,673 | Aug 6, 2009 |
| Frost Gamma Investments Trust | — | Sale | 11,300 | $7.01 | $79,213 | 9,726,173 | Jul 31, 2009 |
| Frost Gamma Investments Trust | — | Sale | 600 | $6.21 | $3,726 | 9,778,573 | Jul 24, 2009 |
| Maimon Yossi | VP, Chief Financial Officer | Sale | 40,000 | $5.13 | $205,200 | — | Jul 7, 2009 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 80,000 | $5.13 | $410,400 | 1,383,754 | Jul 6, 2009 |
| Almon Einat Brill | VP, Product Development | Sale | 11,000 | $4.95 | $54,450 | — | Jul 6, 2009 |
| Maimon Yossi | VP, Chief Financial Officer | Tax Withholding | 10,348 | $3.79 | $39,219 | 30,000 | May 18, 2009 |
| Almon Einat Brill | VP, Product Development | Tax Withholding | 4,707 | $3.79 | $17,840 | 40,000 | May 18, 2009 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 20,000 | $3.51 | $70,200 | 1,473,754 | May 14, 2009 |
| Aviezer David | President & CEO | Option Exercise | 103,571 | $0.12 | $12,429 | — | May 12, 2009 |
| Aviezer David | President & CEO | Option Exercise | 78,061 | $0.12 | $9,367 | — | May 4, 2009 |
| Aviezer David | President & CEO | Tax Withholding | 2,469 | $2.55 | $6,296 | — | Apr 20, 2009 |
| Maimon Yossi | VP, Chief Financial Officer | Sale | 32,241 | $2.22 | $71,575 | — | Mar 13, 2009 |
| Shaaltiel Yoseph | Executive VP, R&D | Sale | 8,300 | $2.18 | $18,094 | 1,493,754 | Mar 13, 2009 |
| Frost Gamma Investments Trust | — | Purchase | 1,000 | $1.66 | $1,660 | 9,781,273 | Oct 10, 2008 |
| Almon Einat Brill | VP, Product Development | Option Exercise | 48,370 | $0.40 | $19,348 | 48,370 | May 12, 2008 |
| Frost Gamma Investment Trust | — | Purchase | 1,400 | $2.87 | $4,018 | 9,768,273 | Mar 11, 2008 |
| Yossi Maimon | VP, Chief Financial Officer | Sale | 33,300 | $3.18 | $105,894 | 26,700 | Feb 22, 2008 |
| Shaaltiel Yoseph | Executive VP, R&D | Purchase | 100 | $3.35 | $335 | 2,964,307 | Dec 17, 2007 |